Research Isn’t Abstract Science But a Pathway to Answers, Treatments, and Hope – ASH
American Society of Hematology shared a post on LinkedIn:
“On Rare Disease Day, let’s remember that research isn’t abstract science but a pathway to answers, treatments, and hope.
For people living with rare blood disorders, every new study, discovery, and clinical trial brings us closer to better diagnostics, safer therapies, and improved quality of life.
The ASH Research Awards Fund supports innovative research that can transform care for rare blood diseases—from early-stage ideas to breakthrough treatments.
When you give, you’re directly fueling the work that patients and families are counting on.
Your support helps to:
- Advance promising research in rare blood disorders
- Accelerate the development of new treatment options
- Bring hope to patients and families worldwide
Together, we can turn rare disease research into real-world impact for the people who need it most.”
Other posts about American Society of Hematology on Hemostasis Today.
-
Sep 12, 2026, 07:02Melissa Hollo: Pre-Operative Anemia – An Underrecognized Challenge in Surgical Care
-
Sep 12, 2026, 06:57Klaus Metzeler: ESH 2026 MDS Conference – Connecting Experts Across Hematology
-
Sep 12, 2026, 06:40Lakmali Silva: Fibrinolysis and Its Role in Hematopoietic Recovery After Chemotherapy
-
Sep 12, 2026, 06:30Alexander Misono: Improving DVT Diagnosis and Care Through Venous Duplex Ultrasound
-
Sep 12, 2026, 06:06Simone Cesaro: GNE-Related Thrombocytopenia – New Findings
-
Sep 12, 2026, 04:11Jyotishbhai Patel: Why India Needs Universal Newborn Screening for Sickle Cell and Thalassemia
-
Sep 12, 2026, 04:04Oliver Schlager: New ESC and ESVM Clinical Consensus on Lipid-Lowering Therapy in VTE
-
Sep 12, 2026, 03:54Toby Richards: Representing IronLife at Parliament on Anaemia and Iron Deficiency
-
Sep 12, 2026, 03:50Saleh Shamse Basha: When ‘Low Protein S’ Isn’t Necessarily Low